Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
To better understand the mechanism of chemoresistance in ovarian cancer cells, we aimed to investigate the influence of macrophages on the tumor cell response to carboplatin and identify the genes associated with chemoresistance. We mimicked the tumor microenvironment (TME) using a co-culture techni...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910707/?tool=EBI |
_version_ | 1811166140252028928 |
---|---|
author | Yong Soo Jang Tae Wan Kim Jae Sung Ryu Hye Jeong Kong Si Hyeong Jang Gye Hyun Nam Jae Hoon Kim Seob Jeon |
author_facet | Yong Soo Jang Tae Wan Kim Jae Sung Ryu Hye Jeong Kong Si Hyeong Jang Gye Hyun Nam Jae Hoon Kim Seob Jeon |
author_sort | Yong Soo Jang |
collection | DOAJ |
description | To better understand the mechanism of chemoresistance in ovarian cancer cells, we aimed to investigate the influence of macrophages on the tumor cell response to carboplatin and identify the genes associated with chemoresistance. We mimicked the tumor microenvironment (TME) using a co-culture technique and compared the proliferation of ovarian cells with and without macrophages. We also examined M1 and M2 marker expression and the expression of key TME genes. Post the co-culture, we treated ovarian cancer cells with carboplatin and elucidated the function of programmed death–ligand 1 (PD-L1) in carboplatin chemoresistance. We investigated CD68 and PD-L1 expression in normal and cancerous ovarian tissues using immunohistochemistry (IHC). Finally, we analyzed the association between CD68 or PD-L1 expression and survival outcomes. Inducible nitric oxide synthase (iNOS) was downregulated, while the gene expression of M2 macrophage markers was increased in ovarian cancer cells. PD-L1, vascular endothelial growth factor (VEGF), Interleukin (IL)-6, IL-10, IL-12, signal transducer and activator of transcription 3 (STAT3), B-cell lymphoma 2 (BCL2), multidrug resistance 1 (MDR1), and colony stimulating factor 1 (CSF-1) were upregulated. Notably, PD-L1 was upregulated in both the ovarian cancer cells and macrophages. Ovarian cancer cells co-cultured with macrophages exhibited statistically significant carboplatin resistance compared to single-cultured ovarian cancer cells. PD-L1 silencing induced chemosensitivity in both types of co-cultured ovarian cancer cells. However, IHC results revealed no correlation between PD-L1 expression and patient survival or cancer stage. CD68 expression was significantly increased in cancer cells compared to normal or benign ovarian tumor cells, but it was not associated with the survival outcomes of ovarian cancer patients. Our study demonstrated that ovarian cancer cells interact with macrophages to induce the M2 phenotype. We also established that PD-L1 upregulation in both ovarian cancer cells and macrophages is a key factor for carboplatin chemoresistance. |
first_indexed | 2024-04-10T15:47:43Z |
format | Article |
id | doaj.art-ae891557ffa04efca2b2e20e2b2fb05a |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-10T15:47:43Z |
publishDate | 2023-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-ae891557ffa04efca2b2e20e2b2fb05a2023-02-12T05:31:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01182Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cellsYong Soo JangTae Wan KimJae Sung RyuHye Jeong KongSi Hyeong JangGye Hyun NamJae Hoon KimSeob JeonTo better understand the mechanism of chemoresistance in ovarian cancer cells, we aimed to investigate the influence of macrophages on the tumor cell response to carboplatin and identify the genes associated with chemoresistance. We mimicked the tumor microenvironment (TME) using a co-culture technique and compared the proliferation of ovarian cells with and without macrophages. We also examined M1 and M2 marker expression and the expression of key TME genes. Post the co-culture, we treated ovarian cancer cells with carboplatin and elucidated the function of programmed death–ligand 1 (PD-L1) in carboplatin chemoresistance. We investigated CD68 and PD-L1 expression in normal and cancerous ovarian tissues using immunohistochemistry (IHC). Finally, we analyzed the association between CD68 or PD-L1 expression and survival outcomes. Inducible nitric oxide synthase (iNOS) was downregulated, while the gene expression of M2 macrophage markers was increased in ovarian cancer cells. PD-L1, vascular endothelial growth factor (VEGF), Interleukin (IL)-6, IL-10, IL-12, signal transducer and activator of transcription 3 (STAT3), B-cell lymphoma 2 (BCL2), multidrug resistance 1 (MDR1), and colony stimulating factor 1 (CSF-1) were upregulated. Notably, PD-L1 was upregulated in both the ovarian cancer cells and macrophages. Ovarian cancer cells co-cultured with macrophages exhibited statistically significant carboplatin resistance compared to single-cultured ovarian cancer cells. PD-L1 silencing induced chemosensitivity in both types of co-cultured ovarian cancer cells. However, IHC results revealed no correlation between PD-L1 expression and patient survival or cancer stage. CD68 expression was significantly increased in cancer cells compared to normal or benign ovarian tumor cells, but it was not associated with the survival outcomes of ovarian cancer patients. Our study demonstrated that ovarian cancer cells interact with macrophages to induce the M2 phenotype. We also established that PD-L1 upregulation in both ovarian cancer cells and macrophages is a key factor for carboplatin chemoresistance.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910707/?tool=EBI |
spellingShingle | Yong Soo Jang Tae Wan Kim Jae Sung Ryu Hye Jeong Kong Si Hyeong Jang Gye Hyun Nam Jae Hoon Kim Seob Jeon Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells PLoS ONE |
title | Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells |
title_full | Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells |
title_fullStr | Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells |
title_full_unstemmed | Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells |
title_short | Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells |
title_sort | upregulation of programmed death ligand 1 in tumor associated macrophages affects chemotherapeutic response in ovarian cancer cells |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910707/?tool=EBI |
work_keys_str_mv | AT yongsoojang upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells AT taewankim upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells AT jaesungryu upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells AT hyejeongkong upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells AT sihyeongjang upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells AT gyehyunnam upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells AT jaehoonkim upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells AT seobjeon upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells |